Blood Glucose and Hyperglycaemia Management in Hospital for Adults with Diabetes Clinical Guideline V2.0. March 2018

Size: px
Start display at page:

Download "Blood Glucose and Hyperglycaemia Management in Hospital for Adults with Diabetes Clinical Guideline V2.0. March 2018"

Transcription

1 Blood Glucose and Hyperglycaemia Management in Hospital for Adults with Diabetes Clinical Guideline V2.0 March 2018 Page 1 of 8

2 Summary flow chart for monitoring of blood glucose if >11mmol/L For Adults without a diagnosis of diabetes refer to Diagnosis Guideline Capillary blood glucose < 4mmol/l refer to Hypoglycaemia Guideline Diagnosis of Type 1 Diabetes Capillary blood Glucose > 11 mmol/l Diagnosis of Type 2 Diabetes further action required Elevated capillary blood glucose >15mmol/l Elevated capillary blood glucose >15mmol/l Medical Review of Current Insulin Treatment And consider if any of the following have occurred? 1. Insulin omitted / missed 2. The patient taking steroid therapy? 3. There is any sign of infection? 4. There is any suspicion of Acute Coronary Syndrome? (Refer to Guideline) 1. Test urine for Ketones 2. Administer PRN vorapid as prescribed (if this is outside of meal times must have medical review prior to administration) 2. If ketones present for medical review of patient and usual insulin regimen 3. Repeat capillary blood glucose in 1 hour 4. If capillary blood glucose >15 mmol/l for two consecutive blood sugar readings 1 hours apart: Accompanied by ketones, profound dehydration, intense thirst, polyuria and / or drowsiness consider Diabetic Ketoacidosis immediate referral for medical review t accompanied by ketones, profound dehydration, intense thirst, polyuria and / or drowsiness - Refer to Dr / Diabetes team to assess existing and on-going insulin regimen Monitor glucose trends 4 times a day 2 of 8 Monitor glucose trends twice daily at varying times Medical Review of Current Treatment And consider if any of the following have occurred? 1. Insulin / Tablets omitted / missed 2. The patient taking steroid therapy? 3. There is any sign of infection? 4. There is any suspicion of Acute Coronary Syndrome? (Refer to Guideline) 1. Test urine for Ketones 2. Administer PRN vorapid as prescribed (if this is outside of meal times must have medical review prior to administration) 3. Gain medical review 4. Repeat capillary blood glucose in 1 hour 5. If capillary blood glucose > 33 mmol/l for two consecutive readings 2 hours apart: Commence Intravenous Insulin Infusion and t Accompanied by profound dehydration, Intense thirst, Polyuria or drowsiness - Dr/Diabetes team to assess existing and on-going treatment regimen Accompanied by profound dehydration, intense thirst, polyuria or drowsiness consider Hyperosmolar Hyperglycaemic State (HHS) immediate referral for medical review Elevated capillary blood glucose >33mmol/l 1. Test Urine for ketones 2. If ketones present gain medical review If capillary blood glucose consistently > 15mmol/l without ketones gain medical review of current diabetes treatment

3 1. Aim/Purpose of this Guideline This guideline is for the management of the blood glucose of Adult patients with Diabetes Mellitus within Secondary Care 2. The Guidance Please see Summary flow chart for monitoring of blood glucose if >11mmol/L 3. Monitoring compliance and effectiveness Element to be monitored Lead Tool Frequency Reporting arrangements Acting on recommendations and Lead(s) Compliance with the relevant process for patients seen at a Diabetes Team Review. Specialist Adult In-Patient Diabetes Team Patient Documentation Adult in-patients with diabetes who are reviewed by the specialist diabetes team n-compliance will be reported to the responsible medical team, ward /area manager. n-compliance resulting in an adverse patient event will be reported via Datix Relevant Datixes will be reviewed at Endocrine Governance Meeting Medical teams / ward / area managers will undertake subsequent recommendations and action planning for any or all deficiencies and recommendations within reasonable timeframes for their areas The Specialist Adult In-Patient Diabetes Team will undertake any trust wide recommendations and action planning for any or all deficiencies and recommendations within reasonable timeframes Change in practice and lessons to be shared Lesson learned or changes to practice will be shared with all the relevant stakeholders 4. Equality and Diversity 4.1. This document complies with the Royal Cornwall Hospitals NHS Trust service Equality and Diversity statement which can be found in the 'Equality, Diversity & Human Rights Policy' or the Equality and Diversity website Equality Impact Assessment The Initial Equality Impact Assessment Screening Form is at Appendix 2. 3 of 8

4 .Appendix 1. Governance Information Document Title Management of Blood Glucose and Hyperglycaemia in Hospital for Adults with Diabetes Clinical Guideline V2.0 Date Issued/Approved: 23 March 2018 Date Valid From: 23 March 2018 Date Valid To: 23 March 2021 Directorate / Department responsible (author/owner): Amanda Veall Lead Diabetes Specialist Nurse Contact details: Brief summary of contents Suggested Keywords: Target Audience Executive Director responsible for Policy: Clinical Guidance for the management of blood glucose for adults with diabetes whilst in hospital Diabetes Blood Glucose RCHT CPFT KCCG Medical Director Date revised: 13/01/18 This document replaces (exact title of previous version): Approval route (names of committees)/consultation: Divisional Manager confirming approval processes Name and Post Title of additional signatories Signature of Executive Director giving approval Publication Location (refer to Policy on Policies Approvals and Ratification): Document Library Folder/Sub Folder Clinical guideline for the Management of Blood Glucose and Hyperglycaemia in Hospital for Adults with Diabetes V1.1 Diabetes In-Patient Specialist Nurses, Consultant Endocrinologists, Consultant Physician Medical Admission Roz Davies t Required {Original Copy Signed} Internet & Intranet Intranet Only Clinical / Endocrine and Diabetes Links to key external standards DoH:NSF Diabetes 2001 standard 8 4 of 8

5 Related Documents: Training Need Identified? ne Version Control Table Date Version 28 Jan 15 V1.0 Initial Issue Summary of Changes 19 v 15 V1.1 And Hyperglycaemia added to title 23 Mar 18 V2.0 IV insulin infusion added for B/G > 33 Changes Made by (Name and Job Title) Amanda Veall, Lead Diabetes Specialist Nurse Amanda Veall, Lead Diabetes Specialist Nurse Amanda Veall Lead Diabetes Specialist Nurse All or part of this document can be released under the Freedom of Information Act 2000 This document is to be retained for 10 years from the date of expiry. This document is only valid on the day of printing Controlled Document This document has been created following the Royal Cornwall Hospitals NHS Trust Policy on Document Production. It should not be altered in any way without the express permission of the author or their Line Manager. 5 of 8

6 Appendix 2. Initial Equality Impact Assessment Form Name of the strategy / policy /proposal / service function to be assessed Management of Blood Glucose and Hyperglycaemia in Hospital for Adults with Diabetes Clinical Guideline V2.0 Directorate and service area: Endocrinology Name of individual completing assessment: Amanda Veall 1. Policy Aim* Who is the strategy / policy / proposal / service function aimed at? Is this a new or existing Policy? Existing Telephone: To provide detailed guidance on the clinical management of blood glucose for adults with diabetes admitted to secondary care 2. Policy Objectives* To provide a consistent approach to the management of blood glucose for adults with diabetes within Secondary care To maintain patient safety and improve outcomes for adults with diabetes within secondary care 3. Policy intended Consistent management of blood glucose in RCHT sites Outcomes* 4. *How will you measure the outcome? 5. Who is intended to benefit from the policy? 6a Who did you consult with b). Please identify the groups who have been consulted about this procedure. Audit Datix Reporting Review of medical/ nursing documentation as required All adult patients with diabetes in RCHT Workforce Patients Local groups Please record specific names of groups Consultant Endocrinologists Consultant Physician Medical Admissions Diabetes Specialist Nurses External organisations Other What was the outcome Approved by all of the consultation? 7. The Impact Please complete the following table. If you are unsure/don t know if there is a negative impact you need to repeat the consultation step. Are there concerns that the policy could have differential impact on: Equality Strands: Unsure Rationale for Assessment / Existing Evidence Age Sex (male, female, trans-gender / gender reassignment) 6 of 8

7 Race / Ethnic communities /groups Disability - Learning disability, physical impairment, sensory impairment, mental health conditions and some long term health conditions. Religion / other beliefs Marriage and Civil partnership Pregnancy and maternity Sexual Orientation, Bisexual, Gay, heterosexual, Lesbian You will need to continue to a full Equality Impact Assessment if the following have been highlighted: You have ticked in any column above and consultation or evidence of there being consultation- this excludes any policies which have been identified as not requiring consultation. or Major this relates to service redesign or development 8. Please indicate if a full equality analysis is recommended. 9. If you are not recommending a Full Impact assessment please explain why. Signature of policy developer / lead manager / director Date of completion and submission 20/04/2018 Names and signatures of members carrying out the Screening Assessment 1. Amanda Veall. DSN Lead 2. Human Rights, Equality & Inclusion Lead Keep one copy and send a copy to the Human Rights, Equality and Inclusion Lead c/o Royal Cornwall Hospitals NHS Trust, Human Resources Department, Knowledge Spa, Truro, Cornwall, TR1 3HD This EIA will not be uploaded to the Trust website without the signature of the Human Rights, Equality & Inclusion Lead. A summary of the results will be published on the Trust s web site. Signed Amanda Veall Date 20/04/ of 8

8 8 of 8

DIAGNOSIS AND MANAGEMENT OF PYLORIC STENOSIS IN CHILDREN CLINICAL GUIDELINE V3.0

DIAGNOSIS AND MANAGEMENT OF PYLORIC STENOSIS IN CHILDREN CLINICAL GUIDELINE V3.0 DIAGNOSIS AND MANAGEMENT OF PYLORIC STENOSIS IN CHILDREN CLINICAL GUIDELINE V3.0 1. Aim/Purpose of this Guideline This guideline is relevant to all medical and nursing staff caring for children with Pyloric

More information

CLINICAL GUIDELINE FOR THE MANAGEMENT OF BARRETT S OESOPHAGUS Summary.

CLINICAL GUIDELINE FOR THE MANAGEMENT OF BARRETT S OESOPHAGUS Summary. CLINICAL GUIDELINE FOR THE MANAGEMENT OF BARRETT S OESOPHAGUS Summary. Page 1 of 12 Recurrent LGD at any point- discuss at MDT And consider RFA Patients with LGD should have a repeat endoscopy in 6 months.

More information

Clinical Guideline for Intravenous Opioids for Adults in Recovery Areas The Recovery Protocol

Clinical Guideline for Intravenous Opioids for Adults in Recovery Areas The Recovery Protocol Clinical Guideline for Intravenous Opioids for Adults in Recovery Areas The Recovery Protocol 1. Aim/Purpose of this Guideline 1.1. To Provide safe and efficient administration of Opioids in Recovery.

More information

SALBUTAMOL INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline

SALBUTAMOL INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline SALBUTAMOL INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline 1.1. This Patient Group Direction (PGD) applies to all nursing and clinical staff in the Child Health Department

More information

CLINICAL GUIDELINE FOR THE ADMINISTRATION OF MESNA WITH IFOSFAMIDE AND CYCLOPHOSPHAMIDE Summary.

CLINICAL GUIDELINE FOR THE ADMINISTRATION OF MESNA WITH IFOSFAMIDE AND CYCLOPHOSPHAMIDE Summary. CLINICAL GUIDELINE FOR THE ADMINISTRATION OF MESNA WITH IFOSFAMIDE AND CYCLOPHOSPHAMIDE Summary. Yes Is patient prescribed ifosfamide or cyclophosphamide >1g/m 2? Chemotherapy prescription on Aria should

More information

CLINICAL GUIDELINE FOR THE ADMINISTRATION OF NEBULISED PENTAMIDINE Summary. 1.

CLINICAL GUIDELINE FOR THE ADMINISTRATION OF NEBULISED PENTAMIDINE Summary. 1. CLINICAL GUIDELINE FOR THE ADMINISTRATION OF NEBULISED PENTAMIDINE Summary. 1. Patient requires nebulised Pentamidine Ensure equipment listed is available Ensure HEPA filtered room in Haematology Clinic

More information

28 th September Author Jeremy Gilbert Bariatric Nurse Specialist

28 th September Author Jeremy Gilbert Bariatric Nurse Specialist POLICY FOR SELF ADMINISTRATION OF CONTINUOUS POSITIVE AIRWAY PRESSURE BY COMPETENT PATIENTS COMING IN FOR METABOLIC AND OBESITY SURGERY (BARIATRIC SURGERY) TO PENDENNIS WARD 28 th September 2014 Author

More information

METABOLIC BONE DISEASE OF PREMATURITY NEONATAL CLINICAL GUIDELINE V3.0

METABOLIC BONE DISEASE OF PREMATURITY NEONATAL CLINICAL GUIDELINE V3.0 METABOLIC BONE DISEASE OF PREMATURITY NEONATAL CLINICAL GUIDELINE V3.0 Page 1 of 10 1. Aim/Purpose of this Guideline To provide guidance on the prevention of metabolic bone disease in the neonate. All

More information

Hypoglycaemia in Adults with Diabetes Clinical Guideline V5.0. March 2018

Hypoglycaemia in Adults with Diabetes Clinical Guideline V5.0. March 2018 March 2018 Page 1 of 11 Adult with Diabetes and blood glucose < 4 mmol/l Treatment as per Guideline: Nursing / Clinical Staff Patient reviewed as per guideline guidance notes: Nursing / Clinical Staff

More information

School Hearing Screening Policy

School Hearing Screening Policy School Hearing Screening Policy V2.1 1st August 2017 Page 1 of 13 Table of Contents 1. Introduction... 3 2. Purpose of this Policy... 3 3. Scope... 3 4. Definitions / Glossary... 3 5. Ownership and Responsibilities...

More information

SHARED CARE GUIDELINE FOR BUCCAL MIDAZOLAM FOR THE TREATMENT OF PROLONGED SEIZURES IN CHILDREN

SHARED CARE GUIDELINE FOR BUCCAL MIDAZOLAM FOR THE TREATMENT OF PROLONGED SEIZURES IN CHILDREN SHARED CARE GUIDELINE FOR BUCCAL MIDAZOLAM FOR THE TREATMENT OF PROLONGED SEIZURES IN CHILDREN 1. Aim/Purpose of this Guideline 1.1. This guideline applies to medical, nursing and pharmacy staff in the

More information

Start. What is the serum phosphate concentration? Moderate Hypophosphataemia mmol/l. Replace using oral. phosphate. (See section 3.

Start. What is the serum phosphate concentration? Moderate Hypophosphataemia mmol/l. Replace using oral. phosphate. (See section 3. CLINICAL GUIDELINE FOR THE MANAGEMENT OF HYPOPHOSPHATAEMIA IN ADULTS Summary. Key: General Notes GP/SWASFT ED/MAU/SRU/Acute GP/Amb-Care In-patient wards Start What is the serum concentration? Mild Hypophosphataemia

More information

1.1. This guideline applies to medical, nursing and pharmacy staff in the safe and appropriate prescription and administration of acamprosate.

1.1. This guideline applies to medical, nursing and pharmacy staff in the safe and appropriate prescription and administration of acamprosate. SHARED CARE GUIDELINE FOR ACAMPROSATE 1. Aim/Purpose of this Guideline 1.1. This guideline applies to medical, nursing and pharmacy staff in the safe and appropriate prescription and administration of

More information

GESTATIONAL DIABETES MELLITUS AND SUBSEQUENT MANAGEMENT OF CONFIRMED GESTATIONAL DIABETES MELLITUS (GDM) AND SELECTIVE SCREENING - CLINICAL GUIDELINE

GESTATIONAL DIABETES MELLITUS AND SUBSEQUENT MANAGEMENT OF CONFIRMED GESTATIONAL DIABETES MELLITUS (GDM) AND SELECTIVE SCREENING - CLINICAL GUIDELINE GESTATIONAL DIABETES MELLITUS AND SUBSEQUENT MANAGEMENT OF CONFIRMED GESTATIONAL DIABETES MELLITUS (GDM) AND SELECTIVE SCREENING - CLINICAL GUIDELINE V 1.5 2017 Screening - Clinical Guideline Page 1 of

More information

HYPOSPADIAS NEONATAL CLINICAL GUIDELINE. 1. Aim/Purpose of this Guideline. 2. The Guidance

HYPOSPADIAS NEONATAL CLINICAL GUIDELINE. 1. Aim/Purpose of this Guideline. 2. The Guidance HYPOSPADIAS NEONATAL CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline 1.1. This guideline applies to all staff managing the initial care of infants born with hypospadias. It includes assessment and

More information

Fasting for Adults (including Young Adults Age 16+ years) who require Anaesthesia or Intravenous Sedation Clinical Guideline V5.0

Fasting for Adults (including Young Adults Age 16+ years) who require Anaesthesia or Intravenous Sedation Clinical Guideline V5.0 Fasting for Adults (including Young Adults Age 16+ years) who require Anaesthesia or Intravenous Sedation November 2018 Summary. Fasting for Adults (including Young Adults Age 16+ years) who require Anaesthesia

More information

PRESEPTAL AND ORBITAL CELLULITIS IN CHILDREN- CLINICAL GUIDELINE V3.0

PRESEPTAL AND ORBITAL CELLULITIS IN CHILDREN- CLINICAL GUIDELINE V3.0 PRESEPTAL AND ORBITAL CELLULITIS IN CHILDREN- CLINICAL GUIDELINE V3.0 Page 1 of 8 1. Aim/Purpose of this Guideline 1.1. This guideline applies to medical and nursing staff caring for a child with Preseptal

More information

CLINICAL GUIDELINE FOR MANAGEMENT OF NEUTROPENIC SEPSIS IN ADULT CANCER PATIENTS (this guideline excludes haematology patients)

CLINICAL GUIDELINE FOR MANAGEMENT OF NEUTROPENIC SEPSIS IN ADULT CANCER PATIENTS (this guideline excludes haematology patients) CLINICAL GUIDELINE FOR MANAGEMENT OF NEUTROPENIC SEPSIS IN ADULT CANCER PATIENTS (this guideline excludes haematology patients) 1. Aim/Purpose of this Guideline 1.1. Systemic cancer treatments and immunological

More information

CLINICAL GUIDELINE FOR INTRAVENOUS FLUID THERAPY FOR ADULTS IN HOSPITAL 1. Aim/Purpose of this Guideline

CLINICAL GUIDELINE FOR INTRAVENOUS FLUID THERAPY FOR ADULTS IN HOSPITAL 1. Aim/Purpose of this Guideline CLINICAL GUIDELINE FOR INTRAVENOUS FLUID THERAPY FOR ADULTS IN HOSPITAL 1. Aim/Purpose of this Guideline 1.1. This guideline contains recommendations about general principles for managing intravenous (IV)

More information

MANAGEMENT OF THE BLADDER IN THE POSTOPERATIVE PERIOD FOLLOWING UNCOMPLICATED GYNAECOLOGICAL SURGERY CLINICAL GUIDELINES

MANAGEMENT OF THE BLADDER IN THE POSTOPERATIVE PERIOD FOLLOWING UNCOMPLICATED GYNAECOLOGICAL SURGERY CLINICAL GUIDELINES MANAGEMENT OF THE BLADDER IN THE POSTOPERATIVE PERIOD FOLLOWING UNCOMPLICATED GYNAECOLOGICAL SURGERY CLINICAL GUIDELINES 1. Aim/Purpose of this Guideline All clinical staff working in the Division of women,

More information

CLINICAL GUIDELINE FOR THE MANAGEMENT OF HYPOKALAEMIA

CLINICAL GUIDELINE FOR THE MANAGEMENT OF HYPOKALAEMIA POLICY UNDER REVIEW Please note that this policy is under review. It does, however, remain current Trust policy subject to any recent legislative changes, national policy instruction (NHS or Department

More information

CLINICAL GUIDELINE FOR THE MANAGEMENT OF HIGH BLOOD GLUCOSE LEVELS AND SICK DAYS FOR INSULIN PUMP USERS UNDER THE PAEDIATRIC DIABETES SERVICE. V4.

CLINICAL GUIDELINE FOR THE MANAGEMENT OF HIGH BLOOD GLUCOSE LEVELS AND SICK DAYS FOR INSULIN PUMP USERS UNDER THE PAEDIATRIC DIABETES SERVICE. V4. CLINICAL GUIDELINE FOR THE MANAGEMENT OF HIGH BLOOD GLUCOSE LEVELS AND SICK DAYS FOR INSULIN PUMP USERS UNDER THE PAEDIATRIC DIABETES SERVICE. V4.1 Page 1 of 11 1. Aim/Purpose of this Guideline 1.1. The

More information

Captopril and Enalapril (Ace Inhibitor) Therapy Clinical Guideline V1.0

Captopril and Enalapril (Ace Inhibitor) Therapy Clinical Guideline V1.0 Captopril and Enalapril (Ace Inhibitor) Therapy Clinical Guideline V1.0 November 2018 Summary Prescribing, monitoring and administration of Captopril and Enalapril FOR STAFF PATIENTS Medical and Nursing

More information

Clinical guideline for the introduction of Sacubitril Valsartan in primary and secondary care in Cornwall

Clinical guideline for the introduction of Sacubitril Valsartan in primary and secondary care in Cornwall Clinical guideline for the introduction of Sacubitril Valsartan in primary and secondary care in Cornwall Page 1 of 15 Summary Patient clinically assessed and reviewed by a Consultant Cardiologist, Cardiology

More information

MANAGEMENT OF NEONATAL HYPOTENSION CLINICAL GUIDELINE

MANAGEMENT OF NEONATAL HYPOTENSION CLINICAL GUIDELINE MANAGEMENT OF NEONATAL HYPOTENSION CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline 1.1. To provide guidance on the assessment and management of infants with hypotension. All involved will benefit from

More information

SHARED CARE GUIDELINE FOR RIFAXIMIN FOR PREVENTING EPISODES OF OVERT HEPATIC ENCEPHALOPATHY IN ADULT PATIENTS 1. Aim/Purpose of this Guideline

SHARED CARE GUIDELINE FOR RIFAXIMIN FOR PREVENTING EPISODES OF OVERT HEPATIC ENCEPHALOPATHY IN ADULT PATIENTS 1. Aim/Purpose of this Guideline SHARED CARE GUIDELINE FOR RIFAXIMIN FOR PREVENTING EPISODES OF OVERT HEPATIC ENCEPHALOPATHY IN ADULT PATIENTS 1. Aim/Purpose of this Guideline 1.1. This guideline applies to medical, nursing and pharmacy

More information

SHARED CARE GUIDELINE FOR MODAFINIL 1. Aim/Purpose of this Guideline. 2. The Guidance

SHARED CARE GUIDELINE FOR MODAFINIL 1. Aim/Purpose of this Guideline. 2. The Guidance SHARED CARE GUIDELINE FOR MODAFINIL 1. Aim/Purpose of this Guideline 1.1. This guideline applies to medical, nursing and pharmacy staff in the safe and appropriate prescription and administration of modafinil.

More information

Patient Controlled Analgesia/Intravenous Opiate Infusion in Child Health Clinical Guideline V4.0 October 2018

Patient Controlled Analgesia/Intravenous Opiate Infusion in Child Health Clinical Guideline V4.0 October 2018 Patient Controlled Analgesia/Intravenous Opiate Infusion in Child Health Clinical Guideline V4.0 October 2018 Page 1 of 12 1. Aim/Purpose of this Guideline Guideline for children with a Patient Controlled

More information

CLINICAL GUIDELINE FOR THE MANAGEMENT OF ANAPHYLAXIS IN INFANTS AND CHILDREN UNDER SIXTEEN YEARS OF AGE V3.0

CLINICAL GUIDELINE FOR THE MANAGEMENT OF ANAPHYLAXIS IN INFANTS AND CHILDREN UNDER SIXTEEN YEARS OF AGE V3.0 CLINICAL GUIDELINE FOR THE MANAGEMENT OF ANAPHYLAIS IN INFANTS AND CHILDREN UNDER SITEEN YEARS OF AGE V3.0 Page 1 of 16 1. Aim/Purpose of this Guideline 1.1. The purpose of this guideline is to provide

More information

CLINICAL GUIDELINE FOR MANAGEMENT OF GALLSTONES PATHOLOGY IN ADULTS

CLINICAL GUIDELINE FOR MANAGEMENT OF GALLSTONES PATHOLOGY IN ADULTS CLINICAL GUIDELINE FOR MANAGEMENT OF GALLSTONES PATHOLOGY IN ADULTS 1. Aim/Purpose of this Guideline This guideline is for the management of gallstones pathology in adults. It has been benchmarked against

More information

CLINICAL GUIDELINE FOR USE OF A PATIENT CONTROLLED ANALGESIA OR INTRAVENOUS OPIATE INFUSION IN CHILD HEALTH. 1. Aim/Purpose of this Guideline

CLINICAL GUIDELINE FOR USE OF A PATIENT CONTROLLED ANALGESIA OR INTRAVENOUS OPIATE INFUSION IN CHILD HEALTH. 1. Aim/Purpose of this Guideline CLINICAL GUIDELINE FOR USE OF A PATIENT CONTROLLED ANALGESIA OR INTRAVENOUS OPIATE INFUSION IN CHILD HEALTH. 1. Aim/Purpose of this Guideline Guideline for children with a Patient Controlled Analgesia

More information

CLINICAL GUIDELINE FOR NEONATAL BCG VACCINATION V3.0

CLINICAL GUIDELINE FOR NEONATAL BCG VACCINATION V3.0 CLINICAL GUIDELINE FOR NEONATAL BCG VACCINATION V3.0 Page 1 of 11 1. Aim/Purpose of this Guideline 1.1. Tuberculosis is a notifiable disease in the UK and although incidence is low it remains a Public

More information

DIABETES IN PREGNANCY, TYPE 1 AND TYPE 2 DIABETES MELLITUS (DM), CLINICAL GUIDELINE FOR MIDWIVES V1.4

DIABETES IN PREGNANCY, TYPE 1 AND TYPE 2 DIABETES MELLITUS (DM), CLINICAL GUIDELINE FOR MIDWIVES V1.4 DIABETES IN PREGNANCY, TYPE 1 AND TYPE 2 DIABETES MELLITUS (DM), CLINICAL GUIDELINE FOR MIDWIVES V1.4 1 1. Aim/Purpose of this Guideline To provide guidance to Midwives, Obstetricians and the Joint Obstetric/Diabetes

More information

Procedure for Subcutaneous Injection of Insulin or GLP1 Analogue in Adults Using a Pen Device V2.0

Procedure for Subcutaneous Injection of Insulin or GLP1 Analogue in Adults Using a Pen Device V2.0 Procedure for Subcutaneous Injection of Insulin or GLP1 Analogue in Adults Using a Pen Device V2.0 11 October 2017 Table of Contents 1. Introduction.. 3 2. Purpose of this Policy/Procedure. 3 3. Scope

More information

Prevention and Treatment of Mucositis in Children and Young People with Cancer Clinical Guideline V3.1 December 2018

Prevention and Treatment of Mucositis in Children and Young People with Cancer Clinical Guideline V3.1 December 2018 Prevention and Treatment of Mucositis in Children and Young People with Cancer Clinical Guideline V3.1 December 2018 1. Aim/Purpose of this Guideline This guideline applies to all medical and nursing staff

More information

Suspected Pulmonary embolus Ambulatory Pathway. Document Title. Date Issued/Approved: Date Valid From: 11/11/17. Date Valid To: 11/05/18

Suspected Pulmonary embolus Ambulatory Pathway. Document Title. Date Issued/Approved: Date Valid From: 11/11/17. Date Valid To: 11/05/18 POLICY UNDER REVIEW Please note that this policy is under review. It does, however, remain current Trust policy subject to any recent legislative changes, national policy instruction (NHS or Department

More information

CLINICAL GUIDELINE FOR AN EPIDURAL INFUSION IN CHILD HEALTH 1. Aim/Purpose of this Guideline

CLINICAL GUIDELINE FOR AN EPIDURAL INFUSION IN CHILD HEALTH 1. Aim/Purpose of this Guideline CLINICAL GUIDELINE FOR AN EPIDURAL INFUSION IN CHILD HEALTH 1. Aim/Purpose of this Guideline 1.1. The purpose of this guideline is to provide guidance on caring for children who are receiving epidural

More information

CLINICAL GUIDELINE FOR THE MANAGEMENT OF HYPONATRAEMIA Summary. Start. End. Key: Na + below normal range ( mmol/L) Symptomatic?

CLINICAL GUIDELINE FOR THE MANAGEMENT OF HYPONATRAEMIA Summary. Start. End. Key: Na + below normal range ( mmol/L) Symptomatic? CLINICAL GUIDELINE FOR THE MANAGEMENT OF HYPONATRAEMIA Summary Key: General tes ED/MAU/SRU/Acute GP/Amb-Care GP/SWASFT In-patient wards Start Na + below normal range (135 145mmol/L) Refer to endocrinology

More information

CLINICAL PROCEDURE FOR THE SAFE REMOVAL OF FEMORAL ARTERIAL SHEATHS USING A DIGITAL APPROACH 1. Aim/Purpose of this Guideline

CLINICAL PROCEDURE FOR THE SAFE REMOVAL OF FEMORAL ARTERIAL SHEATHS USING A DIGITAL APPROACH 1. Aim/Purpose of this Guideline POLICY UNDER REVIEW Please note that this policy is under review. It does, however, remain current Trust policy subject to any recent legislative changes, national policy instruction (NHS or Department

More information

CLINICAL GUIDELINE FOR THE USE OF PHENYTOIN IN EPILEPSY

CLINICAL GUIDELINE FOR THE USE OF PHENYTOIN IN EPILEPSY This applies to adult patients only CLINICAL GUIDELINE FOR THE USE OF PHENYTOIN IN EPILEPSY Key: General Notes ED/MAU/SRU/Acute GP/Amb-Care GP/SWASFT In-patient wards Start Yes Patient already taking phenytoin?

More information

The Management of Children and Young People with Newly Presenting Diabetes Clinical Guideline V5.0 December 2018

The Management of Children and Young People with Newly Presenting Diabetes Clinical Guideline V5.0 December 2018 The Management of Children and Young People with Newly Presenting Diabetes Clinical Guideline December 2018 Summary GP suspects diabetes Under 16 years or still in School Year 11 NO Refer Adults YES Section

More information

CLINICAL GUIDELINE FOR THE MANAGEMENT OF CONVULSIVE STATUS EPILEPTICUS IN CHILDHOOD V3.0

CLINICAL GUIDELINE FOR THE MANAGEMENT OF CONVULSIVE STATUS EPILEPTICUS IN CHILDHOOD V3.0 CLINICAL GUIDELINE FOR THE MANAGEMENT OF CONVULSIVE STATUS EPILEPTICUS IN CHILDHOOD V3.0 Clinical Guideline Template Page 1 of 14 1. Aim/Purpose of this Guideline 1.1. This guideline applies to all nursing

More information

MUCOSITIS IN CHILDREN AND YOUNG PEOPLE WITH CANCER- CLINICAL GUIDELINE FOR PREVENTION AND TREATMENT V3.0

MUCOSITIS IN CHILDREN AND YOUNG PEOPLE WITH CANCER- CLINICAL GUIDELINE FOR PREVENTION AND TREATMENT V3.0 MUCOSITIS IN CHILDREN AND YOUNG PEOPLE WITH CANCER- CLINICAL GUIDELINE FOR PREVENTION AND TREATMENT V3.0 Page 1 of 10 1. Aim/Purpose of this Guideline 1.1. This guideline applies to all medical and nursing

More information

MANAGEMENT OF DIABETES MELLITUS (DM) IN PREGNANCY TYPE 1, TYPE 2 AND GESTATIONAL DIABETES (GDM),CLINICAL GUIDELINE. V1.0

MANAGEMENT OF DIABETES MELLITUS (DM) IN PREGNANCY TYPE 1, TYPE 2 AND GESTATIONAL DIABETES (GDM),CLINICAL GUIDELINE. V1.0 MANAGEMENT OF DIABETES MELLITUS (DM) IN PREGNANCY TYPE 1, TYPE 2 AND GESTATIONAL DIABETES (GDM),CLINICAL GUIDELINE. V1.0 1 1. Aim/Purpose of this Guideline To provide guidance to Midwives, Obstetricians

More information

Osteoblasts (cells which form new bone) Osteoclasts (cells which break down old bone)

Osteoblasts (cells which form new bone) Osteoclasts (cells which break down old bone) Clinical guideline for the administration of Bisphosphonates and other drugs affecting bone metabolism in Haematology and Oncology patients 1. Aim/Purpose of this Guideline 1.1. To provide education to

More information

CLINICAL GUIDELINE FOR THE MANAGEMENT OF VIRAL LARYNGO-TRACHEOBRONCHITIS (CROUP) V3.0

CLINICAL GUIDELINE FOR THE MANAGEMENT OF VIRAL LARYNGO-TRACHEOBRONCHITIS (CROUP) V3.0 CLINICAL GUIDELINE FOR THE MANAGEMENT OF VIRAL LARYNGO-TRACHEOBRONCHITIS (CROUP) V3.0 Clinical Guideline Template Page 1 of 13 1. Aim/Purpose of this Guideline 1.1. This guideline applies to all nursing

More information

SHARED CARE GUIDELINE FOR TREATMENT OF DEMENTIA 1. Aim/Purpose of this Guideline

SHARED CARE GUIDELINE FOR TREATMENT OF DEMENTIA 1. Aim/Purpose of this Guideline POLICY UNDER REVIEW Please note that this policy is under review. It does, however, remain current Trust policy subject to any recent legislative changes, national policy instruction (NHS or Department

More information

In Hospital Management of Hypoglycaemia in Adults with Diabetes Mellitus

In Hospital Management of Hypoglycaemia in Adults with Diabetes Mellitus In Hospital Management of Hypoglycaemia in Adults with Diabetes Mellitus This procedural document supersedes any previous guidelines in relation to this subject: PAT/T 49 v.2 In Hospital Management of

More information

Pelvic Inflammatory Disease Clinical Guideline V1.0 February 2019

Pelvic Inflammatory Disease Clinical Guideline V1.0 February 2019 Pelvic Inflammatory Disease Clinical Guideline V1.0 February 2019 Summary This guideline will provide evidence based guidance on the management of Pelvic Inflammatory Disease A low threshold for empirical

More information

SHARED CARE GUIDELINE FOR LITHIUM. 1. Aim/Purpose of this Guideline. 2. The Guidance

SHARED CARE GUIDELINE FOR LITHIUM. 1. Aim/Purpose of this Guideline. 2. The Guidance SHARED CARE GUIDELINE FOR LITHIUM 1. Aim/Purpose of this Guideline 1.1. This guideline applies to medical, nursing and pharmacy staff in the safe and appropriate prescription and administration of lithium.

More information

CLINICAL GUIDELINE FOR MANAGEMENT OF ACUTE CHOLECYSTITIS IN ADULTS

CLINICAL GUIDELINE FOR MANAGEMENT OF ACUTE CHOLECYSTITIS IN ADULTS CLINICAL GUIDELINE FOR MANAGEMENT OF ACUTE CHOLECYSTITIS IN ADULTS 1. Aim/Purpose of this Guideline This guideline is for the management of acute cholecystitis in adults. It has been benchmarked against

More information

CLINICAL GUIDELINE FOR THE EVALUATION OF A CHILD PRESENTING WITH FEVER AND SEIZURE V3.0

CLINICAL GUIDELINE FOR THE EVALUATION OF A CHILD PRESENTING WITH FEVER AND SEIZURE V3.0 CLINICAL GUIDELINE FOR THE EVALUATION OF A CHILD PRESENTING WITH FEVER AND SEIZURE V3.0 Clinical Guideline Template Page 1 of 18 Page 1 of 13 1. Aim/Purpose of this Guideline 1.1. This guideline applies

More information

SHARED CARE GUIDELINE FOR MYCOPHENOLATE MOFETIL FOR RHEUMATOLOGY INDICATIONS 1. Aim/Purpose of this Guideline

SHARED CARE GUIDELINE FOR MYCOPHENOLATE MOFETIL FOR RHEUMATOLOGY INDICATIONS 1. Aim/Purpose of this Guideline SHARED CARE GUIDELINE FOR MYCOPHENOLATE MOFETIL FOR RHEUMATOLOGY INDICATIONS 1. Aim/Purpose of this Guideline 1.1. This guideline applies to medical, nursing and pharmacy staff in the safe and appropriate

More information

Melatonin shared care guideline. Document Title. Corporate: Clinical. Type of document. Brief summary of contents

Melatonin shared care guideline. Document Title. Corporate: Clinical. Type of document. Brief summary of contents Document Title Melatonin shared care guideline Type of document Corporate: Clinical Brief summary of contents Executive Director responsible for Policy: Directorate / Department responsible (author/owner):

More information

Clinical Guideline for the Management of Pot Operative Atrial Fibrillation

Clinical Guideline for the Management of Pot Operative Atrial Fibrillation Clinical Guideline for the Management of Pot Operative Atrial Fibrillation 1. Aim/Purpose of this Guideline 1.1. Atrial Fibrillation is the most common cardiac arrhythmia with a prevalence of around 0.5%

More information

Clinical Guideline for the management of paediatric patients with Diabetes Type 1 & 2 requiring Surgery or General Anaesthetic. V4

Clinical Guideline for the management of paediatric patients with Diabetes Type 1 & 2 requiring Surgery or General Anaesthetic. V4 Clinical Guideline for the management of paediatric patients with Diabetes Type 1 & 2 requiring Surgery or General Anaesthetic. V4 Page 1 of 27 Abbreviation Meaning PDSN DKA BG SC IV RCHT HDU PEWS Paediatric

More information

Spirometry Clinical Guideline V2.0. May 2018

Spirometry Clinical Guideline V2.0. May 2018 Spirometry Clinical Guideline V2.0 May 2018 Spirometry Clinical Guideline V2.0 1 Summary REFERRAL FOR SPIROMETRY QUALITY ASSURED SPIROMETRY PERFORMED BY TECHNICIAN TRAINED AND ASSESSED AS COMPETENT SPIROMETRY

More information

Managing Hyperglycaemia in Acute (Adult) Inpatients Requiring Enteral Feeding Guidelines

Managing Hyperglycaemia in Acute (Adult) Inpatients Requiring Enteral Feeding Guidelines Document Control Title Managing Hyperglycaemia in Acute (Adult) Inpatients Requiring Author Author s job title Specialist Nurse Consultant Physician Department Directorate Unscheduled Care Version Date

More information

Admission of a Child/Young Person with Cystic Fibrosis Clinical Guideline V3.0 May 2018

Admission of a Child/Young Person with Cystic Fibrosis Clinical Guideline V3.0 May 2018 Admission of a Child/Young Person with Cystic Fibrosis Clinical Guideline V3.0 May 2018 Page 1 of 16 1. Aim/Purpose of this Guideline This guideline applies to all staff caring for children/young people

More information

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Pre-filled Patient Controlled Analgesia (PCA) syringes

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Pre-filled Patient Controlled Analgesia (PCA) syringes The Newcastle upon Tyne Hospitals NHS Foundation Trust Pre-filled Patient Controlled Analgesia (PCA) syringes Version.: 2.2 Effective From: 1 June 2016 Expiry Date: 1 June 2019 Date Ratified: 20 April

More information

CLINICAL GUIDELINE FOR THE MANAGEMENT OF INPATIENTS WITH PARKINSON S DISEASE

CLINICAL GUIDELINE FOR THE MANAGEMENT OF INPATIENTS WITH PARKINSON S DISEASE CLINICAL GUIDELINE FOR THE MANAGEMENT OF INPATIENTS WITH PARKINSON S DISEASE 1. Aim/Purpose of this Guideline To assist all doctors and nurses in the care of inpatients with Parkinson s disease. This guideline

More information

Title Management of Children and Young People with Newly Diagnosed Type 1 Diabetes Mellitus Guideline

Title Management of Children and Young People with Newly Diagnosed Type 1 Diabetes Mellitus Guideline Document Control Title Management of Children and Young People with Newly Diagnosed Type 1 Diabetes Mellitus Guideline Author Directorate Version Author s job title Consultant Paediatrician Department

More information

Patients undergoing Bariatric surgery with type 2 diabetes on antidiabetic drugs WITHOUT insulin, when starting liver shrinking diet: Guidance for GPs

Patients undergoing Bariatric surgery with type 2 diabetes on antidiabetic drugs WITHOUT insulin, when starting liver shrinking diet: Guidance for GPs Patients undergoing Bariatric surgery with type 2 diabetes on antidiabetic drugs WITHOUT insulin, when starting liver shrinking diet: Guidance for GPs Subject: Policy Number Ratified By: Patients with

More information

PALIPERIDONE LONG ACTING INJECTION PRESCRIBING GUIDELINE. Chief Pharmacist. Chief Pharmacist

PALIPERIDONE LONG ACTING INJECTION PRESCRIBING GUIDELINE. Chief Pharmacist. Chief Pharmacist REFERENCE NUMBER: PALIPERIDONE LONG ACTING INJECTION PRESCRIBING GUIDELINE AREA: NAME OF RESPONSIBLE COMMITTEE / INDIVIDUAL NAME OF ORIGINATOR / AUTHOR Trust-wide Chief Pharmacist Chief Pharmacist DATE

More information

PROCEDURE FOR BLOOD GLUCOSE MONITORING

PROCEDURE FOR BLOOD GLUCOSE MONITORING PROCEDURE FOR BLOOD GLUCOSE MONITORING First Issued Issue Version Two Purpose of Issue/Description of Change Planned Review Date To promote safe and effective blood glucose monitoring using Trust equipment

More information

Acute Alcohol Withdrawal Protocol

Acute Alcohol Withdrawal Protocol Acute Alcohol Withdrawal Protocol Controlled document This document is uncontrolled when downloaded or printed Reference number Version 1 Author WHHT: C268 Dr Mohamed Shariff Date ratified August 2014

More information

This guideline was adapted in collaboration with Dr Georgina Walker and the Palliative Care Team at Rowcroft Hospice. With thanks.

This guideline was adapted in collaboration with Dr Georgina Walker and the Palliative Care Team at Rowcroft Hospice. With thanks. Title: Directorate: Responsible for review: Ratified by: DIABETES, MANAGEMENT OF IN PALLIATIVE CARE PATIENTS General Medicine Diabetes Specialist Nurse Service Delivery Unit Clinical Director of Pharmacy

More information

GUIDELINE FOR ENTERAL TUBE FEEDING (NASOGASTRIC OR PEG) IN PATIENTS WITH DIABETES MELLITUS TREATED WITH INSULIN

GUIDELINE FOR ENTERAL TUBE FEEDING (NASOGASTRIC OR PEG) IN PATIENTS WITH DIABETES MELLITUS TREATED WITH INSULIN GUIDELINE FOR ENTERAL TUBE FEEDING (NASOGASTRIC OR PEG) IN PATIENTS WITH DIABETES MELLITUS TREATED WITH INSULIN This guidance does not override the individual responsibility of health professionals to

More information

Blood Transfusion Policy for Children and Neonates. November 2017

Blood Transfusion Policy for Children and Neonates. November 2017 Blood Transfusion Policy for Children and Neonates V5 November 2017 1. Introduction 3 2. Purpose of this Policy/Procedure 3 3. Scope 3 4. Ownership and Responsibilities 3 4.1. Role of the Managers 3 4.2.

More information

Trust Protocol for the Administration of Intravenous Methylprednisolone for Thyroid Eye Disease A Protocol. The Clinical Investigation Unit (CIU)

Trust Protocol for the Administration of Intravenous Methylprednisolone for Thyroid Eye Disease A Protocol. The Clinical Investigation Unit (CIU) A Protocol For Use in: By: For: Division responsible for document: Key words: Name of document author: Job title of document author: Name and job title of document author s Line Manager: Supported by:

More information

Lynda Astbury Lead Diabetes Specialist Nurse

Lynda Astbury Lead Diabetes Specialist Nurse Lynda Astbury Lead Diabetes Specialist Nurse WARNING SIGNS AND SYMPTOMS Is patient Feeling unwell? Blood glucose level above 13mmol/L Or higher than the patients day to day readings (even if not eating)

More information

Adult Chest Wall Injury Pathway V2.0 May 2018

Adult Chest Wall Injury Pathway V2.0 May 2018 ` Adult Chest Wall Injury Pathway V2.0 May 2018 Page 1 of 22 Summary Adult Chest Wall Injury Pathway Blunt chest wall injury requiring admission. Trauma Call if appropriate. Strongly consider Trauma CT.

More information

SHARED CARE GUIDELINE FOR CICLOSPORIN IN DERMATOLOGY. 1. Aim/Purpose of this Guideline. 2. The Guidance

SHARED CARE GUIDELINE FOR CICLOSPORIN IN DERMATOLOGY. 1. Aim/Purpose of this Guideline. 2. The Guidance SHARED CARE GUIDELINE FOR CICLOSPORIN IN DERMATOLOGY 1. Aim/Purpose of this Guideline 1.1. This guideline applies to medical, nursing and pharmacy staff in the safe and appropriate prescription and administration

More information

Pathway for Adult Patients with Diabetes attending the Emergency Department (ED) with Hypoglycaemia

Pathway for Adult Patients with Diabetes attending the Emergency Department (ED) with Hypoglycaemia Leicestershirediabetes Guidelines Pathway for Adult Patients with Diabetes attending the Emergency Department (ED) with Hypoglycaemia Patient attends ED Support available from Diabetes Specialist Nurses

More information

CLINICAL GUIDELINE FOR ANTIEMETIC USE IN PAEDIATRIC ONCOLOGY 1. Aim/Purpose of this Guideline

CLINICAL GUIDELINE FOR ANTIEMETIC USE IN PAEDIATRIC ONCOLOGY 1. Aim/Purpose of this Guideline CLINICAL GUIDELINE FOR ANTIEMETIC USE IN PAEDIATRIC ONCOLOGY 1. Aim/Purpose of this Guideline 1.1. This guideline applies to medical and nursing staff working with paediatric oncology patients. 2. The

More information

National Diabetes Inpatient Audit (NaDIA) 2016

National Diabetes Inpatient Audit (NaDIA) 2016 National Diabetes Inpatient Audit (NaDIA) 2016 DIABETES A summary report for people with diabetes and anyone interested in the quality of care for people with diabetes when they stay in hospital. Based

More information

AROMATHERAPY - CLINICAL GUIDELINE FOR MIDWIVES. January 2018

AROMATHERAPY - CLINICAL GUIDELINE FOR MIDWIVES. January 2018 AROMATHERAPY - CLINICAL GUIDELINE FOR MIDWIVES V2 January 2018 1. Aim/Purpose of this Guideline 1.1. Aromatherapy is the use of essential oils, which can be administered by topical application via massage,

More information

Acutely Painful testes

Acutely Painful testes 2.0 FINAL Guideline adopted from the Bedside Clinical Guideline Partnership EQUALITY IMPACT The Trust strives to ensure equality of opportunity for all both as a major employer and as a provider of health

More information

Executive Summary Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules)

Executive Summary Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules) Executive Summary Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules) SETTING FOR STAFF PATIENTS Medical and nursing staff Children and young

More information

Diabetes Emergency Caesarean section or other unplanned surgery (GL822)

Diabetes Emergency Caesarean section or other unplanned surgery (GL822) Diabetes Emergency Caesarean section or other unplanned surgery (GL822) i.e. insulin dependent diabetic having unplanned surgery e.g. a diabetic woman with pre-labour SROM prior to elective Caesarean section.

More information

Developing a pathway of. and care planning for people with diabetes

Developing a pathway of. and care planning for people with diabetes Developing a pathway of preoperative assessment and care planning for people with diabetes Louise Hilton, Marie Digner Diabetes is a common endocrine condition affecting 1.4 million people in the UK, with

More information

NO SMOKING POLICY. Organisational

NO SMOKING POLICY. Organisational NO SMOKING POLICY Policy Title State previous title where relevant. State if Policy New or Revised Policy Strand Org, HR, Clinical, H&S, Infection Control, Finance For clinical policies only - state index

More information

Title Use of Pre-Operative Tests for Elective Surgery Guideline. Department. Anaesthetics. Comment / Changes / Approval

Title Use of Pre-Operative Tests for Elective Surgery Guideline. Department. Anaesthetics. Comment / Changes / Approval Document Control Title Use of Pre-Operative Tests for Elective Surgery Guideline Author Consultant Anaesthetist Author s job title Consultant Anaesthetist Directorate Clinical Support Services Department

More information

Staff at the Nottingham Children s Hospital. Guidelines process.

Staff at the Nottingham Children s Hospital. Guidelines  process. Diabetes and Surgery Title of Guideline Contact Name and Job Title (author) Guideline for the management of children and young people with diabetes aged 18 or under requiring surgery Dr Priyha Santhanam,

More information

Integrated Community Diabetes Services (ICDS) GP Referral Guide Version 3 - October 2014

Integrated Community Diabetes Services (ICDS) GP Referral Guide Version 3 - October 2014 Integrated Community Diabetes Services (ICDS) GP Referral Guide Version 3 - October 2014 Introduction The Integrated Community Diabetes Service (ICDS) will deliver high quality care to individuals who

More information

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Religion, Belief and Cultural Practice Policy Meeting the needs of Patients and Carers

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Religion, Belief and Cultural Practice Policy Meeting the needs of Patients and Carers The Newcastle upon Tyne Hospitals NHS Foundation Trust Religion, Belief and Cultural Practice Policy Meeting the needs of Patients and Carers Version No.: 3.2 Effective From: 13 March 2018 Expiry Date:

More information

Consultation Group: Dr Amalia Mayo, Paediatric Consultant. Review Date: March Uncontrolled when printed. Version 2. Executive Sign-Off

Consultation Group: Dr Amalia Mayo, Paediatric Consultant. Review Date: March Uncontrolled when printed. Version 2. Executive Sign-Off Policy For The Adjustment Of Insulin Injections By Paediatric Diabetes Specialist Nurses/Community Paediatric Nurses Diabetes Working With Children Within NHS Grampian Co-ordinators: Lead Paediatric Diabetes

More information

31 December a programme of dates of meetings for Full Council, Policy Page: 241 Committees, and Area Committees for the twelve months commencing 1 May

31 December a programme of dates of meetings for Full Council, Policy Page: 241 Committees, and Area Committees for the twelve months commencing 1 May Page: 240 Business Services REPORT TO ABERDEENSHIRE COUNCIL 28 SEPTEMBER, 2017 TIMETABLE OF MEETINGS 2018/19 1 Recommendation 1.1 The Council is recommended to approve the timetable of Council, Policy

More information

OBSESSIVE COMPULSIVE DISORDER

OBSESSIVE COMPULSIVE DISORDER SHARED CARE GUIDELINE FOR SSRIs for the treatment of DEPRESSION, OBSESSIVE COMPULSIVE DISORDER and ANXIETY in CHILDREN and YOUNG PEOPLE 1. Aim/Purpose of this Guideline 1.1. This guideline applies to medical,

More information

Specialised Services Commissioning Policy. CP29: Bariatric Surgery

Specialised Services Commissioning Policy. CP29: Bariatric Surgery Specialised Services Commissioning Policy CP29: Bariatric Surgery Document Author: Specialist Planner, Cardiothoracic Executive Lead: Director of Planning Approved by: Management Group Issue Date: 12 June

More information

Trust Policy 218 Ionising Radiation Safety Policy

Trust Policy 218 Ionising Radiation Safety Policy Trust Policy 218 Ionising Radiation Safety Policy Purpose Date Version August 2016 7 To ensure that Plymouth Hospitals NHS Trust complies with all relevant legislation with regard to the use of ionising

More information

Falls The Assessment, Prevention and Management of Patient Falls (Adult Services) 1.34

Falls The Assessment, Prevention and Management of Patient Falls (Adult Services) 1.34 SECTION: 1 PATIENT CARE Including Physical Healthcare POLICY /PROCEDURE: 1.34 NATURE AND SCOPE: SUBJECT (Title): POLICY AND PROCEDURE - TRUST WIDE FALLS: THE ASSESSMENT, PREVENTION AND MANAGEMENT OF PATIENT

More information

The most recent estimates suggest that. A study of inpatient diabetes care on medical wards. Saqib Javed, Yaser Javed, Kate Barnabas, Kalpana Kaushal

The most recent estimates suggest that. A study of inpatient diabetes care on medical wards. Saqib Javed, Yaser Javed, Kate Barnabas, Kalpana Kaushal A study of inpatient diabetes care on medical wards Saqib Javed, Yaser Javed, Kate Barnabas, Kalpana Kaushal Article points 1. It is well established that poor glycaemic control is associated with increased

More information

Insert heading depending line on length; please delete delete. length; please delete other cover options once

Insert heading depending line on length; please delete delete. length; please delete other cover options once Insert heading depending Insert on Interim Insert heading line length; Clinical please Commissioning depending on line on length; please delete delete other Policy: on line line cover Circumcision length;

More information

Policy for the Prevention & Management of Occupational Dermatitis and Latex Allergy in a Healthcare Setting V2.0

Policy for the Prevention & Management of Occupational Dermatitis and Latex Allergy in a Healthcare Setting V2.0 Policy for the Prevention & Management of Occupational Dermatitis and Latex Allergy in a Healthcare Setting V2.0 March 2016 Summary Document Title: Policy for the Prevention and Management of Occupational

More information

Trust Policy. Control of Smoking Policy (Patients and Visitors)

Trust Policy. Control of Smoking Policy (Patients and Visitors) Trust Policy Control of Smoking Policy (Patients and Visitors) Purpose Date May 2016 Version V3 Final To discharge the Trust s responsibilities under the Health Act 2006, and associated NICE Guidelines

More information

Smoke Free Policy. Version 2.0

Smoke Free Policy. Version 2.0 Smoke Free Policy Version 2.0 Important: This document can only be considered valid when viewed on the CCG s internet site. If this document has been printed or saved to another location, you must check

More information

Commissioning Policy. Treatment of Snoring. April 2010

Commissioning Policy. Treatment of Snoring. April 2010 Commissioning Policy Treatment of Snoring April 2010 This commissioning policy applies to patients within: South Worcestershire Clinical Commissioning Group (CCG) Redditch & Bromsgrove Clinical Commissioning

More information

Acute Stroke - Management of Hyperglycaemia. Contents

Acute Stroke - Management of Hyperglycaemia. Contents Acute Stroke - Management of Hyperglycaemia Classification: Policy Lead Author: Dr Amir Ahmad Additional author(s): Dr Jouher Kallingal, Professor Bob Young, Professor Pippa Tyrrell Authors Division: :

More information